tiprankstipranks
Advertisement
Advertisement
Zenas BioPharma submits BLA to FDA for obexelimab
PremiumThe FlyZenas BioPharma submits BLA to FDA for obexelimab
3M ago
Insiders Buy the Dip in These 2 Crushed Stocks With Strong Buy Ratings
Premium
Market News
Insiders Buy the Dip in These 2 Crushed Stocks With Strong Buy Ratings
3M ago
Zenas BioPharma Advances Phase 3 Orelabrutinib Trial in Tough MS Segment
Premium
Company Announcements
Zenas BioPharma Advances Phase 3 Orelabrutinib Trial in Tough MS Segment
3M ago
Zenas BioPharma reports Q1 EPS ($1.46) vs. (80c) last year
PremiumThe FlyZenas BioPharma reports Q1 EPS ($1.46) vs. (80c) last year
3M ago
Zenas BioPharma, Inc. (ZBIO) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
Zenas BioPharma, Inc. (ZBIO) Q1 Earnings Cheat Sheet
3M ago
Insiders Are Scooping Up These 2 ‘Strong Buy’ Stocks
Premium
Stock Analysis & Ideas
Insiders Are Scooping Up These 2 ‘Strong Buy’ Stocks
5M ago
Zenas announces common stock, convertible senior notes offerings
PremiumThe FlyZenas announces common stock, convertible senior notes offerings
5M ago
Zenas BioPharma Advances Phase 3 Orelabrutinib Trial in Progressive Multiple Sclerosis
Premium
Company Announcements
Zenas BioPharma Advances Phase 3 Orelabrutinib Trial in Progressive Multiple Sclerosis
5M ago
Zenas BioPharma price target raised to $55 from $45 at Guggenheim
Premium
The Fly
Zenas BioPharma price target raised to $55 from $45 at Guggenheim
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100